Feedback / Questions
lirentelimab (AK002) - Allakos
http://www.ncbi.nlm.nih.gov/pubmed/37403635
Michel Arock; Stéphane Barete
Jul 5, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next